Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography

<div>(a) Deep capillary plexus of study patient before intravitreal treatment of bevacizumab. (b) Deep capillary plexus of study patient after intravitreal treatment of bevacizumab. (c) Structural OCT B-scan after intravitreal treatment of bevacizumab.</div>

Journal of Diabetes Research

fig2

Figure 2

Figure 2: Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography 